Metal-N-C single-atom catalysts(SACs)have emerged as alternatives to platinum for catalyzing the otherwise sluggish oxygen reduction reaction(ORR)[1].Fe-N-CSACs
Background: The outcomes for patients with advanced hepatocellular carcinoma(HCC) receiving sorafenib are far from satisfactory because of treatment resistance